Phase 2 trial of ARINA-1 in chronic obstructive pulmonary disease
Latest Information Update: 24 Sep 2021
At a glance
- Drugs Ascorbic acid/bicarbonate/glutathione (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Renovion
Most Recent Events
- 24 Sep 2021 New trial record
- 21 Sep 2021 According to a Renovion media release, Phase 2 clinical trials are planned to begin in Q1 2022.